Schrauwen I, Sommen M, Claes C, Pinner J, Flaherty M, Collins F, Van Camp G
Department of Medical Genetics, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium.
Clin Genet. 2014 Sep;86(3):282-6. doi: 10.1111/cge.12265. Epub 2013 Sep 23.
Two siblings, from a consanguineous Iraqi family, were investigated to identify the underlying genetic cause of their high myopia, esotropia, vitreous changes and cataract. Subsequent investigation identified low molecular weight proteinuria as part of their syndrome. Exome sequencing of one of the probands revealed a new non-synonymous variant in the LRP2 gene. Sanger sequencing confirmed the mutation and segregation in the family. No mutation was identified in COL9A1/2, COL11A1/2, or COL2A1 genes. The variant (c.11483A>G; p.Asp3828Gly) is predicted to be damaging and is conserved among vertebrate species. Mutations in LRP2 have been shown to cause the Donnai-Barrow syndrome (DBS) or facio-oculo-acoustico-renal (FOAR) syndrome, a syndrome associated with facial dysmorphism, ocular anomalies, sensorineural hearing loss, low molecular weight proteinuria, and diaphragmatic hernia and absent corpus callosum, although there is variability in the expression of some features. This family shows a milder phenotype with a predominant eye phenotype similar to the Stickler syndrome and only a few features of the DBS, including microglobulinuria. The presence of microglobulinuria was only detected after molecular results were known. In conclusion, with the identification of a new mutation in LRP2 associated with a predominant eye phenotype similar to the Stickler syndrome, we have broadened the phenotypic spectrum of LRP2 mutations.
来自伊拉克近亲家庭的两名兄弟姐妹接受了调查,以确定其高度近视、内斜视、玻璃体改变和白内障的潜在遗传原因。随后的调查发现低分子量蛋白尿是其综合征的一部分。对其中一名先证者进行外显子组测序,发现LRP2基因中有一个新的非同义变异。桑格测序证实了该突变在家族中的存在及遗传情况。在COL9A1/2、COL11A1/2或COL2A1基因中未发现突变。该变异(c.11483A>G;p.Asp3828Gly)预计具有损害性,且在脊椎动物物种中保守。LRP2基因的突变已被证明会导致多纳伊-巴罗综合征(DBS)或面-眼-耳-肾(FOAR)综合征,该综合征与面部畸形、眼部异常、感音神经性听力损失、低分子量蛋白尿、膈疝和胼胝体缺失有关,不过某些特征的表现存在变异性。这个家族表现出一种较轻的表型,主要为眼部表型,类似于斯-韦综合征,仅具有DBS的一些特征,包括微球蛋白尿。微球蛋白尿仅在得知分子检测结果后才被发现。总之,通过鉴定出与类似于斯-韦综合征的主要眼部表型相关的LRP2新突变,我们拓宽了LRP2突变的表型谱。